The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.60
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.08 (0.188%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 42.60
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Refinancing of RCF & new sustainability linkage

9 Oct 2023 07:00

RNS Number : 0389P
Assura PLC
09 October 2023

9 October 2023

Assura plc

Refinancing of RCF & new sustainability linkage

Assura plc ("Assura"), the leading primary care property investor and developer, today announces it has refinanced its revolving credit facility ("RCF" or "facility").

The new facility provides Assura with improved terms and flexibility compared to the existing agreement:

- increased from £125 million to £200 million and matures in October 2026

- reduced margin (headline rate 135 basis points with ratchet based on leverage) and overall cost, reflecting the strength of the business

- ability to draw facility in both GBP and EUR

- option to extend the facility by two additional one-year terms (to October 2028), subject to lender approval.

Reflecting Assura's long-term social impact and sustainability targets, the RCF now also includes sustainability-linked KPIs and commitments. Achievement of these KPIs, which are aligned with the existing targets of the business, will result in the margin being adjusted up or down by 5 basis points and the difference being donated to the Assura Community Fund.

The RCF is provided by Barclays Bank PLC, HSBC UK Bank plc, National Westminster Bank plc and Santander UK plc. Assura was advised by Rothschild & Co and Addleshaw Goddard.

Jayne Cottam, CFO, said:

"We are delighted to have increased our RCF to £200 million, extending the long-term relationship we have with our lenders. As well as improving the terms, reflecting the strength of our business, this agreement locks in flexible financing for our future activities.

"Following this agreement, £800 million of our committed facilities now have a sustainability-linkage, aligning our financing with our ambitious ESG targets that are intrinsic to Assura's business model."

- ENDS -

Assura plc David Purcell, Investor Relations Director

Tel: 0161 515 2043 Email: Investor@assura.co.uk

FGS Global

Gordon Simpson

Tel: 0207 251 3801 Email: Assura@fgsglobal.com

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2023, Assura's portfolio was valued at £2.7 billion.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026.

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TSTZZMGGVVGGFZM
Date   Source Headline
20th Sep 201810:26 amRNSScrip Calculation Price
6th Sep 201811:04 amRNSNotice of Dividend
25th Jul 20181:29 pmRNSNotification of Major Interests in Shares
20th Jul 20181:38 pmRNSPDMR Notification
16th Jul 20187:00 amRNSScrip Dividend Declaration
12th Jul 20184:59 pmRNSPricing of £300m senior unsecured bond
10th Jul 20184:28 pmRNSResult of AGM
9th Jul 20182:49 pmRNSNotification of Major Interests in Shares
5th Jul 201810:35 amRNSPDMR notification
5th Jul 20187:00 amRNSTrading Update
4th Jul 20187:00 amRNSChairman Appointment
25th Jun 20184:10 pmRNSCommittee membership
21st Jun 20186:13 pmRNSScrip Calculation Price
7th Jun 20187:00 amRNSNotice of Dividend
7th Jun 20187:00 amRNSAnnual Report & Notice of AGM
1st Jun 201811:40 amRNSNotification of Transaction by PDMR
1st Jun 20187:00 amRNSAppointment of Non-Executive Director
23rd May 20187:00 amRNSAssura Full Year Results
16th May 20187:00 amRNSNotice of Results
27th Apr 20189:44 amRNSNotification of Major Interests in Shares
23rd Apr 20182:37 pmRNSNotification of Major Interests in Shares
23rd Apr 201812:22 pmRNSNotification of Transaction by PDMR
16th Apr 20187:25 amRNSScrip Dividend Declaration
5th Apr 20182:58 pmRNSNotification of Major Interests in Shares
3rd Apr 20187:00 amRNSDirectorate Change
22nd Mar 20183:05 pmRNSScrip Calculation Price
22nd Mar 20187:00 amRNSDirectorate Change
8th Mar 20182:28 pmRNSNotice of Dividend
22nd Feb 20181:16 pmRNSTotal Voting Rights
9th Feb 20181:28 pmRNSPDMR Notification
1st Feb 20187:00 amRNSTrading Update
15th Jan 20189:46 amRNSScrip Dividend Calculation
8th Jan 20183:59 pmRNSDebt redemption
21st Dec 20172:03 pmRNSNotification of Major Interests in Shares
21st Dec 201711:59 amRNSScrip Calculation Price
7th Dec 20174:59 pmRNSNotification of Major Interests in Shares
7th Dec 20174:56 pmRNSNotification of Major Interests in Shares
7th Dec 20173:11 pmRNSNotice of Dividend
7th Dec 201712:06 pmRNSNotification of Major Interests in Shares
7th Dec 201710:28 amRNSDirector/PDMR Shareholding
6th Dec 201710:17 amRNSNotification of Major Interests in Shares
4th Dec 201712:28 pmRNSResult of General Meeting
4th Dec 20177:00 amRNSResult of Proposed Share Issue
30th Nov 20175:29 pmRNSNotification of Major Interests in Shares
17th Nov 20177:00 amRNSCompletion of Bookbuild
16th Nov 20171:02 pmRNSPublication of Prospectus
16th Nov 20177:02 amRNSProposed Share Issue and Notice of GM
16th Nov 20177:00 amRNSInterim Results 2017
1st Nov 201711:24 amRNSTotal Voting Rights
20th Oct 201712:24 pmRNSNote issuance and increased debt facilities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.